WO1993005098A1 - Wettable silicone hydrogel compositions and methods - Google Patents
Wettable silicone hydrogel compositions and methods Download PDFInfo
- Publication number
- WO1993005098A1 WO1993005098A1 PCT/US1992/007322 US9207322W WO9305098A1 WO 1993005098 A1 WO1993005098 A1 WO 1993005098A1 US 9207322 W US9207322 W US 9207322W WO 9305098 A1 WO9305098 A1 WO 9305098A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silicone
- containing monomer
- carbon atoms
- group
- acid
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 68
- 229920001296 polysiloxane Polymers 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims description 43
- 238000000034 method Methods 0.000 title claims description 20
- 239000000178 monomer Substances 0.000 claims abstract description 93
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 11
- 150000008065 acid anhydrides Chemical class 0.000 claims abstract description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 30
- -1 polysiloxane Polymers 0.000 claims description 29
- 239000002253 acid Substances 0.000 claims description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 14
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 14
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 12
- 150000008064 anhydrides Chemical class 0.000 claims description 12
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 claims description 11
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 claims description 11
- 239000004215 Carbon black (E152) Substances 0.000 claims description 9
- 229930195733 hydrocarbon Natural products 0.000 claims description 9
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 8
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 8
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- 239000011976 maleic acid Substances 0.000 claims description 7
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 6
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 239000001530 fumaric acid Substances 0.000 claims description 6
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 5
- BESKSSIEODQWBP-UHFFFAOYSA-N 3-tris(trimethylsilyloxy)silylpropyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCCC[Si](O[Si](C)(C)C)(O[Si](C)(C)C)O[Si](C)(C)C BESKSSIEODQWBP-UHFFFAOYSA-N 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- LFPXMEFNGBINIR-UHFFFAOYSA-N 3,3,3-tris(trimethylsilyloxy)propylsilyl 2-methylprop-2-enoate Chemical compound C[Si](OC(CC[SiH2]OC(C(=C)C)=O)(O[Si](C)(C)C)O[Si](C)(C)C)(C)C LFPXMEFNGBINIR-UHFFFAOYSA-N 0.000 claims description 3
- KYCSFMMJBAZMTE-UHFFFAOYSA-N [2-[methyl(trimethylsilyloxy)silyl]-2-phenylethyl] acetate Chemical compound C[Si](C)(C)O[SiH](C)C(COC(C)=O)C1=CC=CC=C1 KYCSFMMJBAZMTE-UHFFFAOYSA-N 0.000 claims description 3
- RZKKLXUEULTOGP-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]methyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC[Si](C)(C)O[Si](C)(C)C RZKKLXUEULTOGP-UHFFFAOYSA-N 0.000 claims description 3
- YPMNWQTVWVHXIQ-UHFFFAOYSA-N [methyl-bis(trimethylsilyloxy)silyl]methyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C YPMNWQTVWVHXIQ-UHFFFAOYSA-N 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims description 3
- 125000005442 diisocyanate group Chemical group 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 229910052736 halogen Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims 4
- 229910003849 O-Si Inorganic materials 0.000 claims 1
- 229910003872 O—Si Inorganic materials 0.000 claims 1
- 239000000463 material Substances 0.000 description 14
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 13
- 239000001301 oxygen Substances 0.000 description 13
- 229910052760 oxygen Inorganic materials 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000035699 permeability Effects 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 102000016943 Muramidase Human genes 0.000 description 7
- 108010014251 Muramidase Proteins 0.000 description 7
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 7
- 239000004325 lysozyme Substances 0.000 description 7
- 229960000274 lysozyme Drugs 0.000 description 7
- 235000010335 lysozyme Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 5
- 239000004814 polyurethane Substances 0.000 description 5
- 229920002635 polyurethane Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000004971 Cross linker Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000007975 buffered saline Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 4
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 4
- 230000004580 weight loss Effects 0.000 description 4
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 238000009736 wetting Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- JUCOAQCRUJCBPL-BTJKTKAUSA-N (z)-but-2-enedioic acid;2-methylidenebutanedioic acid Chemical compound OC(=O)\C=C/C(O)=O.OC(=O)CC(=C)C(O)=O JUCOAQCRUJCBPL-BTJKTKAUSA-N 0.000 description 2
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 2
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical compound CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000012719 thermal polymerization Methods 0.000 description 2
- BEQKKZICTDFVMG-UHFFFAOYSA-N 1,2,3,4,6-pentaoxepane-5,7-dione Chemical compound O=C1OOOOC(=O)O1 BEQKKZICTDFVMG-UHFFFAOYSA-N 0.000 description 1
- ZXHDVRATSGZISC-UHFFFAOYSA-N 1,2-bis(ethenoxy)ethane Chemical compound C=COCCOC=C ZXHDVRATSGZISC-UHFFFAOYSA-N 0.000 description 1
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- YTEISYFNYGDBRV-UHFFFAOYSA-N [(dimethyl-$l^{3}-silanyl)oxy-dimethylsilyl]oxy-dimethylsilicon Chemical compound C[Si](C)O[Si](C)(C)O[Si](C)C YTEISYFNYGDBRV-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000001609 comparable effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- XJOBOFWTZOKMOH-UHFFFAOYSA-N decanoyl decaneperoxoate Chemical compound CCCCCCCCCC(=O)OOC(=O)CCCCCCCCC XJOBOFWTZOKMOH-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N diethylene glycol diacrylate Substances C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- WARQUFORVQESFF-UHFFFAOYSA-N isocyanatoethene Chemical class C=CN=C=O WARQUFORVQESFF-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000010002 mechanical finishing Methods 0.000 description 1
- YDKNBNOOCSNPNS-UHFFFAOYSA-N methyl 1,3-benzoxazole-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OC)=NC2=C1 YDKNBNOOCSNPNS-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WAUMXMQJIMQTJK-UHFFFAOYSA-N n,n'-dihydroxyocta-2,6-dienediamide Chemical compound ONC(=O)C=CCCC=CC(=O)NO WAUMXMQJIMQTJK-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- XNTUJOTWIMFEQS-UHFFFAOYSA-N octadecanoyl octadecaneperoxoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCCCCCCCC XNTUJOTWIMFEQS-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012745 toughening agent Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- UIYCHXAGWOYNNA-UHFFFAOYSA-N vinyl sulfide Chemical group C=CSC=C UIYCHXAGWOYNNA-UHFFFAOYSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
- C08F299/02—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
- C08F299/08—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polysiloxanes
Definitions
- the present invention relates to improved polymeric silicone-containing hydrogel compositions useful for the production of biomedical devices, especially contact lenses.
- Hydrogels have been a desirable material for the preparation of biomedical devices, and have been known since at least ichterle, et al U.S. Patent No. 3,220,960 which disclosed hydrogels comprising a hydrated polymer of a hydroxyalkyl acrylate or methacrylate crosslinked with a corresponding diester (poly 2-hydroxyethyl methacrylate, known as HEMA) .
- HEMA poly 2-hydroxyethyl methacrylate
- a hydrogel is a hydrated crosslinked polymeric system that contains water in an equilibrium state.
- the physical properties of hydrogels can vary widely and are mostly determined by their water content. Since hydrogels exhibit excellent biocompatibility, there has been extensive interest in the use of hydrogels for biomedical devices, especially contact lenses. In the field of contact lenses, various factors combine to yield a material that has appropriate characteristics. Oxygen permeability, wettability, material strength and stability are but a few of the factors which must be carefully balanced to achieve a useable end-result contact lens. Since the cornea receives its oxygen supply exclusively from contact with the atmosphere, good oxygen permeability is a critical characteristic for any contact lens material.
- High water-containing hydrogels have at times exhibited undesirable mechanical properties. For example, such hydrogels are not easily formed into hydrolytically stable lenses. Further such materials have at times exhibited tearing or other breakage as a result of poor tensile strength. What was needed was a highly oxygen permeable material that was durable and highly wettable. Wettability is important in that if the lens is not sufficiently wettable, it does not remain lubricated and therefore cannot be worn comfortably on the eye. The optimal contact lens would have not only excellent oxygen permeability, but also excellent tear fluid wettability.
- Silicone-containing materials were tried as viable contact lens materials and displayed very good oxygen permeability and durability. However, most silicone- containing materials are largely hydrophobic and therefore not sufficiently wettable. Further, it is believed that such hydrophobicity causes enhanced deposit problems, which may result in discomfort when wearing contact lenses made from these silicone- containing polymers.
- an optimal hydrogel material for biomedical devices such as contact lenses, would have ideal rigidity, high oxygen permeability and a high degree of wettability.
- the surface wettability of hydrogels such as silicone-containing hydrogels, and more specifically urethane prepolymeric hydrogels and ethylenically terminated polysiloxane hydrogels, can be significantly enhanced by the addition of at least one ethylenically unsaturated dibasic acid or corresponding anhydride monomer in the monomer mix. It is believed that these hydrophilic dibasic acid monomers react with the predominantly hydrophobic silicone-containing monomers and prepolymers to produce highly wettable hydrogels.
- a method for making a wettable silicone-containing hydrogel composition comprising the steps of a) combining an ethylenically unsaturated dibasic acid or acid anhydride and at least one silicone- containing prepolymer into a monomer mix and b) curing the monomer mix resulting from step a) to form a silicone-containing hydrogel composition.
- the present invention relates to improved wettability of hydrogels, especially silicone-containing hydrogels with ideal rigidity suitable for biomedical applications such as contact lenses.
- silicone-containing hydrogels of the present invention display improved wettability as a result of the presence of an ethylenically unsaturated dibasic acid or corresponding acid anhydride in the monomer mix with the silicone-containing monomer or prepolymer.
- Silicone hydrogels i.e., hydrogels containing silicone
- silicone-containing monomer or the hydrophilic monomer may function as a crosslinking agent (a crosslinker being defined as a monomer having multiple polymerizable fuctionalities) or a separate crosslinker may be employed.
- any known silicone-containing monomer may be used in the process of this invention to form the silicone hydrogels of this invention, as will be apparent to one skilled in the art.
- the monomers added to the monomeric mixture may be monomers or prepolymers.
- a "prepolymer” is a reaction intermediate polymer of medium molecular weight having polymerizable groups.
- silicon-containing monomers and “hydrophilic monomers” include prepolymers. Examples of such monomers may be found in United States Patent NOS. 4,136,250; 4,153,641; 4,740,533; 5,034,461; and 5,070,215.
- Additional crosslinking agents which may be incorporated into the silicone-containing hydrogel of the present invention include polyvinyl, typically di- or tri-vinyl monomers, most commonly the di- or tri( eth)acrylates of dihydric ethylene glycol, triethylene glycol, butylene glycol, hexane-l,6-diol, thio-diethylene glycol-diacrylate and methacrylate; neopentyl glycol diacrylate; trimethylolpropane triacrylate and the like; N,N'-dihydroxyethylene- bisacrylamide and -bismethacrylamides; also diallyl compounds like diallyl phthalate and triallyl cyanurate; divinylbenzene; ethylene glycol divinyl ether; and the (meth)acrylate esters of polyols such as triethanolamine, glycerol, pentanerythritol, butylene glycol, mannitol, and sorbitol.
- illustrations include N,N-methylene-bis-(meth)acrylamide, sulfonated divinylbenzene, and divinylsulfone.
- reaction products of hydroxyalkyl (meth)acrylates with unsaturated isocyanates for example the reaction product of 2-hydroxyethyl methacrylate with 2- i ⁇ ocyanatoethyl methacrylate (IEM) as disclosed in U.S. Patent No. 4,954,587.
- crosslinking agents are polyether- bisurethane-dimethacrylates as described in U.S. Patent No. 4,192,827, and those crosslinkers obtained by reaction of polyethylene glycol, polypropylene glycol and polytetramethylene glycol with 2-isocyanatoethyl methacrylate (IEM) or m-isopropenyl- , ⁇ -dimethylbenzyl isocyanates (m-TMI) , and polysiloxane-bisurethane- dimethacrylates as described in U.S. Patent Nos. 4,486,577 and 4,605,712.
- IEM 2-isocyanatoethyl methacrylate
- m-TMI m-isopropenyl- , ⁇ -dimethylbenzyl isocyanates
- polysiloxane-bisurethane- dimethacrylates as described in U.S. Patent Nos. 4,486,577 and 4,605,712.
- Still other known crosslinking agents are the reaction products of polyvinyl alcohol, ethoxylated polyvinyl alcohol or of polyvinyl alcohol- co-ethylene with 0.1 to 10 mol % vinyl isocyanates like IEM or m-TMI.
- One preferred class of suitable silicone-containing monomers contemplated by the present invention are bulky polysiloxanylalkyl (meth)acrylic monomers represented by the formula (I) :
- X is 0 or NR; each R is independently hydrogen or methyl; and each R is independently a lower alkyl or phenyl group; and f is 1 or 3 to 10.
- Such bulky monomers include methacryloxypropyl tris(trimethylsiloxy)silane, pentamethyldisiloxanylmethylmethacrylate, tris(trimethylsiloxy)methacryloxy propylsilane, phenyltetramethyldisiloxanylethyl acetate, and methyldi(trimethylsiloxy)methacryloxymethyl silane.
- a further preferred class of silicone-containing monomers is a poly(organosiloxane) prepolymer represented by the formula (II) :
- A is an activated unsaturated group, such as an ester or amide of an acrylic or a methacrylic acid; each R 3 -R 6 is independently selected from the group consisting of a monovalent hydrocarbon radical or a halogen substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may have ether linkages between carbon atoms;
- R 7 is a divalent hydrocarbon radical having from 1 to 22 carbon atoms; and n is 0 or an integer greater than or equal to 1.
- a further preferred class of silicone-containing monomers are the monomers having the following schematic representations:
- D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
- G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
- * denotes a urethane or ureido linkage; a is at least 1;
- A" denotes a divalent polymeric radical of formula (V):
- R s and R s independently denote an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m is at least 1; and p provides a moiety weight of 400 to 10,000;
- E and E' independently denote a polymerizable unsaturated organic radical represented by formula (VI) :
- R 13 -CH C-(CH 2 ) w -(X)x-(2) z -(Ar) y -R 14 - wherein: R 14 denotes a divalent alkylene radical having 1 to 10 carbon atoms;
- R 12 denotes H or CH 3 ;
- Y is -0-, -S- or -NH- and R 15 is a alkyl radical having 1 to 12 carbon atoms;
- X is -CO- or -0C0-
- Z is -O- or -NH-
- Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
- a preferred urethane monomer is represented by formula (VII) : u
- H 2 C C H H H H 1 ( I I COOCH 2 CH 2 OCN-R 16 -NCOCH 2 CH 2 OCH 2 CH 2 OCN-R 16 -NCO
- R 16 is a diradical of a diisocyanate after removal of the isocyanate group, and is most preferably the diradical of isophorone diisocyanate, and m, p and a are the same as previously defined.
- the sum of m and a is 3 or 4, and more preferably, a is 1 and m is 3 or 4.
- p is at least 30.
- hydrogel contact lenses should have oxygen permeabilities with DK values greater than 20 x lO ""11 cm 3 x cm/sec x cm 2 x mmHg (or DK units) and preferably greater than 60 DK. They should have a Young's modulus of elasticity in the range of 5 to 400 g/mm 2 , preferably greater than 20g/mm 2 as measured by ASTM test method D1938. Their water content should be between 10% to 80 %, and preferably between 20 to 60%.
- the contact angle which is a measurement of the wettability of the lens, should be less than 80 degrees and should preferably be less than 40 degrees.
- the present invention further provides articles of manufacture which can be used for biomedical devices, such as, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, catheters, mouth guards, denture liners, intraocular devices, and especially contact lenses.
- biomedical devices such as, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, catheters, mouth guards, denture liners, intraocular devices, and especially contact lenses.
- shaped articles for use in biomedical applications or “biomedical devices” mean the materials disclosed herein have physicochemical properties rendering them suitable for prolonged contact with living tissue, blood and the mucous membranes.
- (meth)acrylaye includes both methyl acrylate and methyl methacrylate
- N-alkyl (meth)acrylamide includes both N-alkyl acrylamide and N-alkyl methacrylamide
- dibasic acid is understood by those skilled in the field to describe compounds which contain groups, each of which supplies an hydrogen atom.
- the resulting polymeric film may have undesirable optical characteristics such as cloudiness, etc.
- dibasic acids only half the weight percent of the amount of monobasic acid need be used to obtain a comparable effect on the polymeric mixture.
- the preferred range of dibasic acid concentration is about from 0.5 weight percent of the polymeric hydrogel mix to about 10 weight percent, and more preferably from about 2 weight percent to about 5 weight percent.
- the resulting hydrogels of the present invention show great promise as a superior material for various biomedical devices such as surgical implants, blood vessels, artificial ureters, artificial breast tissue and membranes intended to come into contact with body fluid outside of the body, e.g., membranes for kidney dialysis and heart/lung machines and the like. It is known that blood, for example, is readily and rapidly damaged when it comes into contact with artificial surfaces. The design of a synthetic surface which is antithrombogenic and nonhemolytic to blood is necessary for prostheses and devices used with blood.
- silicone-containing monomers contemplated by the present invention are urethane-containing prepolymers, and ethylenically terminated polysiloxane containing monomers, such as, most preferably , ⁇ bis(methacryloxybutyl)polysiloxane (M 2 D 2 s) .
- the ethylenically unsaturated dibasic carboxylic acid containing monomer, (or the corresponding anhydride-containing monomer) of the present invention is preferably itaconic acid, maleic acid or their anhydrides, and fumaric acid, and most preferably are itaconic and maleic acid and their anhydrides.
- the monomer mixes employed in this invention can be readily cured to cast shapes by conventional methods such as UV polymerization, or thermal polymerization, or combinations thereof, as commonly used in polymerizing ethylenically unsaturated compounds.
- Representative free radical thermal polymerization initiators are organic peroxides, such as acetal peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, tertiarybutyl peroxypivalate, peroxydicarbonate, and the like, employed in a concentration of about 0.01 to 1 percent by weight of the total monomer mixture.
- Representative UV initiators are those known in the field such as, benzoin methyl ether, benzoin ethyl ether, Darocure 1173, 1164, 2273, / ⁇ -
- Polymerization of the crosslinker of this invention with other comonomers is generally performed in the presence of a diluent.
- the polymerization product will then be in the form of a gel. If the diluent is nonagueous, the diluent must be removed from the gel and replaced with water through the use of extraction and hydration protocols well known to those skilled in the art.
- the copolymer of the present invention may also include other monomers as will be apparent to one skilled in the art.
- the monomer mix may include additional hydrophilic monomers such as N-vinyl pyrrolidone and N,N-dimethylacrylamide, colorants, or UV-absorbing and toughening agents such as those known in the contact lens art.
- the polymers of this invention can be formed into contact lenses by ⁇ pincasting processes (such as those disclosed in U.S. Pat. Nos. 3,408,429 and 3,496,254), cast molding processes (such as those disclosed in U.S.
- Polymerization may be conducted either in a spinning mold, or a stationary mold corresponding to a desired contact lens shape.
- the lens may be further subjected to mechanical finishing, as occasion demands.
- Polymerization may also be conducted in an appropriate mold or vessel to form buttons, plates or rods, which may then be processed
- the hydrogels of the present invention are oxygen transporting, hydrolytically stable, biologically inert, and transparent.
- the monomers and prepolymers employed in accordance with this invention are readily polymerized to form three dimensional networks which permit the transport of oxygen and are optically clear, strong and hydrophilic.
- the relative softness or hardness of the contact lenses fabricated from the resulting polymer of this invention can be varied by deceasing or increasing the molecular weight of the polysiloxane prepolymer end- capped with the activated unsaturated group or by varying the percent of the comonomer. Generally, as the ratio of polysiloxane units to end-cap units increases, the softness of the material increases.
- the hydrophilic ethylenically unsaturated dibasic acid monomers of the present invention significantly reduce the contact angle of the surface - a clear indication to those skilled in the field that enhanced wetting has occurred.
- the resulting dibasic acid- or anhydride-treated silicone- containing hydrogels were unexpectedly hydrolytically stable, within an acceptable range, while collecting only an acceptable level of deposits.
- the resulting polymers and copolymers disclosed herein can be boiled and/or autoclaved in water without being damaged whereby sterilization may be achieved.
- an article formed from the disclosed polymers and copolymers may be used, for example, in surgery where an article is needed which is compatible with living tissue or with the mucous membranes.
- a formulation containing the following was prepared: urethane prepolymer derived from isophorone diisocyanate, diethylene glycol, polysiloxanediol of molecular weight 3000 and 2-hydroxyethyl methacrylate, 35 parts; 3-methacryloxypropyl tris(trimethylsiloxy)silane, (TRIS), 35 parts; N,N- di ethyl acrylamide, 30 parts; n-hexanol, 40 parts; benzoin methyl ether, 0.2 part.
- the resulting clear mix was then UV cured into films or filtered through a 1.2 micron filter into a clean glass vial ready for lens casting.
- Monomer mix was prepared as in Example 1 with the addition of 2 parts of maleic, itaconic or fumaric acid to the monomer mix.
- Monomer mix was prepared as in Example 1 with the addition of 2 parts of itaconic anhydride to the monomer mix.
- the resultant formulations from Examples 1 - 5 were placed between glass plates and cured under UV for 2 hours. After the films were released from the glass, they were extracetd with ethanol for 16 hours and then boiled in water for 4 hours and placed in buffered saline at pH 7.4. The hydrogel films were then characterized for mechanical properties, oxygen permeability, contact angle and others.
- hydrolytic stability data of the control hydrogel film and those modified with two parts of dibasic acids are listed below.
- hydrogel films comprising 2 parts of itaconic acid and maleic acid were considered stable.
- hydrogel films derived from a formulation containing methacrylic acid were not as hydrolytically stable.
- the tests were accomplished by agitating hydrogel films of known weight, (usually 30-40 mg) in a vial containing a standard buffered saline (5 grams) with 500 ppm of lysozyme for a 7 day period.
- the amount of lysozyme remaining in the solution was determined by UV spectroscopy and the lysozyme uptake was reported as micrograms of lysozyme per milligram of hydrogel film, using poly(hydroxyethylmethacrylate) (HEMA) hydrogel films as references.
- HEMA poly(hydroxyethylmethacrylate)
- a high level of lysozome uptake is not desirable in contact lenses. Such uptake decreases visual acuity and can result in adverse eye physiological side effects. While it is desirable to add ionic monomers into the silicone-containing hydrogel to improve wettability, the lysozome uptake level should remain at a low level.
- the contact angles of the surface of the films prepared from formulations in Examples 1 and 2 were measured by the captive bubble technique.
- the films were submerged in buffered saline solution and a bubble of air was attached to the undersurface of the film.
- the angle made by the intersection of the lens and bubble surfaces was measured using a goniometer.
- a lower contact angle represents a greater degree of hydrophilicity, or film surface wettability.
- the comparative contact angles of control hydrogel films and those modified with dibasic acids are listed below.
- a polyurethane monomer mix of composition described in Examples 1 and 2 was filtered through a disposable filter of pore size 1.2 microns, into a clean vial. Through an applicator, under an inert nitrogen atmosphere, 60-9Oul of the mix was injected onto a clean plastic mold (for the anterior surface of a lens) and then covered with a second plastic mold (forming the posterior surface of the lens) . The molds are then compressed and cured for 90 minutes in the presence of ultraviolet light (4200 microwatts/cm 2 ) . The molds were opened mechanically and put in a beaker containing aqueous ethanol. The lenses were released from the mold within 10 to 50 minutes. The lenses were then extracted with ethanol for 48 hours, boiled in distilled water for 4 hours and inspected for cosmetic quality and dimension. Lenses passing inspection were thermally disinfected in phosphate-buffered saline prior to on-eye evaluation.
- the cast molded lenses described in Example 11 were evaluated on six subjects. In each test, a poly(HEMA) control lens was worn on eye one and the test lens on the other eye. The lenses were analyzed after a minimum of one hour of wear, and optimally for 6 hours, for wettability and surface deposition.
- the wettability rating scale was 0-4 with 0 representing 2/3 of the anterior surface unwetted by the tear film and 4 representing complete wetting.
- the deposition scale was also 0-4 with 0 representing no surface deposit and 4 representing multiple deposits of 0.5mm diameter or larger.
- the results for the lenses of the control formulation made according to Example 1, was 2.0 for wetting and 1.6 for deposit after 1 hour of wear.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Physics & Mathematics (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Eyeglasses (AREA)
- Materials For Medical Uses (AREA)
- Polyurethanes Or Polyureas (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Silicon Polymers (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP92919325A EP0603270A1 (en) | 1991-09-12 | 1992-08-28 | Wettable silicone hydrogel compositions and methods for making them |
BR9206600A BR9206600A (en) | 1991-09-12 | 1992-08-28 | Improved method to produce a hydrogel composition containing silicone, humectable, improved composition of hydrogel containing silicone, biomedical device and contact lens |
JP5505326A JPH06510811A (en) | 1991-09-12 | 1992-08-28 | Wettable silicone hydrogel compositions and methods |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US922,595 | 1986-10-24 | ||
US75804791A | 1991-09-12 | 1991-09-12 | |
US758,047 | 1991-09-12 | ||
US92259592A | 1992-07-30 | 1992-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993005098A1 true WO1993005098A1 (en) | 1993-03-18 |
Family
ID=27116484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1992/007322 WO1993005098A1 (en) | 1991-09-12 | 1992-08-28 | Wettable silicone hydrogel compositions and methods |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0603270A1 (en) |
JP (1) | JPH06510811A (en) |
BR (1) | BR9206600A (en) |
CA (1) | CA2116848A1 (en) |
MX (1) | MX9205183A (en) |
WO (1) | WO1993005098A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993023774A1 (en) * | 1992-05-15 | 1993-11-25 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
WO2001070837A1 (en) * | 2000-03-22 | 2001-09-27 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
WO2006034547A1 (en) * | 2004-09-29 | 2006-04-06 | Aortech Biomaterials Pty Ltd | Gels |
WO2007017243A1 (en) * | 2005-08-10 | 2007-02-15 | Novartis Ag | Silicone hydrogels |
US8623986B2 (en) | 2006-04-20 | 2014-01-07 | Aertech International plc | Gels |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19718634A1 (en) * | 1997-05-02 | 1998-11-05 | Wacker Chemie Gmbh | Radiation- or thermosetting organosiloxane compositions with (methyl) styrene groups |
US6020445A (en) * | 1997-10-09 | 2000-02-01 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
WO1999056167A1 (en) * | 1998-04-28 | 1999-11-04 | Toray Industries, Inc. | Process for producing ocular lens |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486577A (en) * | 1982-10-12 | 1984-12-04 | Ciba-Geigy Corporation | Strong, silicone containing polymers with high oxygen permeability |
US4543398A (en) * | 1983-04-28 | 1985-09-24 | Minnesota Mining And Manufacturing Company | Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols |
US4605712A (en) * | 1984-09-24 | 1986-08-12 | Ciba-Geigy Corporation | Unsaturated polysiloxanes and polymers thereof |
US5034461A (en) * | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
EP0291452B1 (en) * | 1987-04-30 | 1994-06-01 | Ciba-Geigy Ag | Terminal polyvinyl functional macromers, polymers thereof and contact lenses made therefrom |
-
1992
- 1992-08-28 WO PCT/US1992/007322 patent/WO1993005098A1/en not_active Application Discontinuation
- 1992-08-28 JP JP5505326A patent/JPH06510811A/en active Pending
- 1992-08-28 CA CA002116848A patent/CA2116848A1/en not_active Abandoned
- 1992-08-28 EP EP92919325A patent/EP0603270A1/en not_active Ceased
- 1992-08-28 BR BR9206600A patent/BR9206600A/en not_active Application Discontinuation
- 1992-09-10 MX MX9205183A patent/MX9205183A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486577A (en) * | 1982-10-12 | 1984-12-04 | Ciba-Geigy Corporation | Strong, silicone containing polymers with high oxygen permeability |
US4543398A (en) * | 1983-04-28 | 1985-09-24 | Minnesota Mining And Manufacturing Company | Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols |
US4605712A (en) * | 1984-09-24 | 1986-08-12 | Ciba-Geigy Corporation | Unsaturated polysiloxanes and polymers thereof |
EP0291452B1 (en) * | 1987-04-30 | 1994-06-01 | Ciba-Geigy Ag | Terminal polyvinyl functional macromers, polymers thereof and contact lenses made therefrom |
US5034461A (en) * | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358995A (en) * | 1992-05-15 | 1994-10-25 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
US5387632A (en) * | 1992-05-15 | 1995-02-07 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
WO1993023774A1 (en) * | 1992-05-15 | 1993-11-25 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
US6367929B1 (en) | 1998-03-02 | 2002-04-09 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
EP2258736A1 (en) * | 2000-03-22 | 2010-12-08 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
WO2001070837A1 (en) * | 2000-03-22 | 2001-09-27 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
US8207245B2 (en) | 2004-09-29 | 2012-06-26 | Aortech International Plc | Gels |
WO2006034547A1 (en) * | 2004-09-29 | 2006-04-06 | Aortech Biomaterials Pty Ltd | Gels |
US7671156B2 (en) | 2005-08-10 | 2010-03-02 | Novartis Ag | Silicone hydrogels |
WO2007017243A1 (en) * | 2005-08-10 | 2007-02-15 | Novartis Ag | Silicone hydrogels |
US8623986B2 (en) | 2006-04-20 | 2014-01-07 | Aertech International plc | Gels |
US9765191B2 (en) | 2006-04-20 | 2017-09-19 | Aortech International Plc | Gels |
US10059807B2 (en) | 2006-04-20 | 2018-08-28 | Aortech International Plc | Gels |
US10597497B2 (en) | 2006-04-20 | 2020-03-24 | Aortech International Plc | Gels |
Also Published As
Publication number | Publication date |
---|---|
BR9206600A (en) | 1995-10-17 |
CA2116848A1 (en) | 1993-03-13 |
JPH06510811A (en) | 1994-12-01 |
MX9205183A (en) | 1993-05-01 |
EP0603270A1 (en) | 1994-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5451617A (en) | Wettable silicone hydrogel compositions and methods for their manufacture | |
CA2121579C (en) | Wettable silicone hydrogel compositions and methods for their manufacture | |
EP0611379B1 (en) | Wettable silicone hydrogel compositions and methods for their manufacture | |
US5496871A (en) | Fumarate and fumaramide siloxane hydrogel compositions | |
US5387632A (en) | Surface wettable silicone hydrogels | |
EP0683799B1 (en) | Fluorosilicone hydrogels | |
HK1008746B (en) | Fluorosilicone hydrogels | |
WO1993005098A1 (en) | Wettable silicone hydrogel compositions and methods | |
US8101698B2 (en) | Surface active prepolymers with both fluorine-containing groups and hydrophilic groups | |
HK1001564B (en) | Wettable silicone hydrogel compositions and methods for their manufacture | |
US20090012250A1 (en) | Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CA JP KR |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2116848 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992919325 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992919325 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1992919325 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992919325 Country of ref document: EP |